Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/25/2014 | WO2014152894A1 Detection of heavy metals in dried blood |
09/25/2014 | WO2014152873A1 Microvesicle histone h2ax as a biomarker for genotoxic stress |
09/25/2014 | WO2014152825A1 Molecular diagnostic devices with magnetic components |
09/25/2014 | WO2014152804A1 Methods and compositions for biomarkers of fatigue, fitness and physical performance capacity |
09/25/2014 | WO2014152796A2 Biocompatible and bioabsorbable derivatized chitosan compositions |
09/25/2014 | WO2014152773A1 Blood biomarkers that predict persistent cognitive dysfunction after concussion |
09/25/2014 | WO2014152758A1 Enrichment of circulating tumor cells by depleting white blood cells |
09/25/2014 | WO2014152640A1 Assay for predictive biomarkers of anti-androgen efficacy |
09/25/2014 | WO2014152610A1 Biomarkers, related methods and systems for predicting loss of muscle mass |
09/25/2014 | WO2014152600A2 Measurement of cellular fmrp levels for high throughput drug screening and diagnosis of fragile x syndrome |
09/25/2014 | WO2014152459A1 Methods of manufacture to optimize performance of transdermal sampling and analysis device |
09/25/2014 | WO2014152443A2 Single-cell analysis as a sensitive and specific method for early prostate cancer detection |
09/25/2014 | WO2014152377A1 Methods for classifying and treating adenocarcinomas |
09/25/2014 | WO2014152322A1 Heterogeneous luminescent oxygen channeling immunoassays |
09/25/2014 | WO2014152298A1 New silicon and germanium dyes for use in genetic identity |
09/25/2014 | WO2014152279A1 Method for quantifying 5-hydroxymethylcytosine |
09/25/2014 | WO2014152233A1 Placebo-controlled gluten challenge method |
09/25/2014 | WO2014152220A1 Identification of candidate target genes for treating neoplasia |
09/25/2014 | WO2014152165A1 Luminescent oxygen channeling immunoassays utilizing electrochemical discharge of singlet oxygen and methods of production and use thereof |
09/25/2014 | WO2014152129A1 A mathematical musical orchestral method for predicting classes of patients for medical treatment |
09/25/2014 | WO2014152086A1 Method of measuring the metabolic indicators of hair follicles |
09/25/2014 | WO2014151940A1 Method and system to predict ssri response |
09/25/2014 | WO2014151885A1 Conjugation of multiple vancomycin molecules on a polyvinyl alcohol backbone for the capture of microorganisms |
09/25/2014 | WO2014151879A2 Method of capturing bacteria on polylysine-coated microspheres |
09/25/2014 | WO2014151846A1 An organic molecule sensor for detecting, differentiating, and measuring organic compounds |
09/25/2014 | WO2014151840A1 Use of cd36 to identify cancer subjects for treatment |
09/25/2014 | WO2014151763A1 Methods of detecting donor-specific antibodies and systems for practicing the same |
09/25/2014 | WO2014151690A1 Device and method for accurate ph monitoring on transparent microarrays |
09/25/2014 | WO2014151658A1 High-speed on demand microfluidic droplet generation and manipulation |
09/25/2014 | WO2014151634A1 Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactions |
09/25/2014 | WO2014151590A1 Heterogeneous luminescent oxygen channeling immunoassays and methods of production and use thereof |
09/25/2014 | WO2014151450A1 Microfluidic distributing device |
09/25/2014 | WO2014151437A1 Urine preservative reagent for microfiltration |
09/25/2014 | WO2014151378A2 Multi-modal fluid condition sensor platform and system thereof |
09/25/2014 | WO2014151374A1 Methods to assess enzyme activity using mass spectrometric immunoassay |
09/25/2014 | WO2014151238A1 Methods for treating and diagnosing systemic lupus erythematosus |
09/25/2014 | WO2014151177A1 Sample concentrator and method of use |
09/25/2014 | WO2014151080A1 Compositions and methods for assessing neuromuscular function |
09/25/2014 | WO2014151079A2 Ratio based biomarkers and methods of use thereof |
09/25/2014 | WO2014151026A1 Genes and gene signatures for diagnosis and treatment of melanoma |
09/25/2014 | WO2014151021A2 Antibody profiling, methods and apparatus for identifying an individual or source of a biological material |
09/25/2014 | WO2014151006A2 Biomarkers and methods of treating pd-1 and pd-l1 related conditions |
09/25/2014 | WO2014150916A1 Systems and methods for improving direct numerical simulation of material properties from rock samples and determining uncertainty in the material properties |
09/25/2014 | WO2014150900A1 Methods and compositions for enhanced analyte detection from blood |
09/25/2014 | WO2014150883A1 Glutamate oxidase mutagenesis for diagnostic testing |
09/25/2014 | WO2014150819A2 Biomarkers and methods of treatment |
09/25/2014 | WO2014150818A1 Immunoassays and methods of detecting and measuring intact fibroblast growth factor 23, and c-terminal and n-terminal fragments thereof |
09/25/2014 | WO2014150688A1 Glycine, mitochondrial one-carbon metabolism, and cancer |
09/25/2014 | WO2014150671A1 Methods of identifying responses to map kinase inhibition therapy |
09/25/2014 | WO2014150374A1 Optical volumetric measurement of a dispensed fluid |
09/25/2014 | WO2014150329A1 Lipid biomarkers of addiction and relapse risk |
09/25/2014 | WO2014150290A1 Devices, systems and methods for sample preparation |
09/25/2014 | WO2014150198A2 Nonalcoholic fatty liver disease (nafld) and nonalcoholic steatohepatitis (nash) biomarkers and uses thereof |
09/25/2014 | WO2014150048A1 Post-steam sterilization moisture-indicating articles |
09/25/2014 | WO2014149744A1 Medical fluid sensors and related systems and methods |
09/25/2014 | WO2014149547A2 Hybrid strip |
09/25/2014 | WO2014149453A1 Diagnostic test device with improved structure |
09/25/2014 | WO2014149383A1 Non-enzyme based method for electronic monitoring of biological indicator |
09/25/2014 | WO2014149382A1 Coupled enzyme-based method for electronic monitoring of biological indicator |
09/25/2014 | WO2014149379A1 Sterilization indicator including a simplified genetically engineered biological indicator |
09/25/2014 | WO2014149310A1 A flow-through cell counting assay |
09/25/2014 | WO2014149196A1 Polymer nanocomposites for early diagnosis of diseases |
09/25/2014 | WO2014149111A1 Assay with increased dynamic range |
09/25/2014 | WO2014148993A1 Method for measuring soap content in black liquor and an analytical container |
09/25/2014 | WO2014148797A1 Novel albumin-copper bond measurement method for measuring albumin in myocardial ischemia |
09/25/2014 | WO2014148780A1 Biomarker for diagnosing liver cancer |
09/25/2014 | WO2014148738A1 Novel korean-type porcine reproductive and respiratory syndrome (prrs) virus |
09/25/2014 | WO2014148646A1 Pluripotent stem cell for neuronal differentiation induction |
09/25/2014 | WO2014148638A1 Aptamer to il-17 and use thereof |
09/25/2014 | WO2014148627A1 Analysis method for assessing stage of prostate cancer, prostate-cancer stage assessment method, prostate-cancer detection method, and test kit |
09/25/2014 | WO2014148601A1 Two-stage reaction system, sample fluid measurement system, and sample fluid measurement method |
09/25/2014 | WO2014148592A1 Method for preparing chondrocytes |
09/25/2014 | WO2014148557A1 Method for predicting sensitivity to egfr inhibitor |
09/25/2014 | WO2014148444A1 ANTI-DOG IgE MONOCLONAL ANTIBODY, AND LIGHT-CHAIN VARIABLE REGION AND HEAVY-CHAIN VARIABLE REGION OF ANTI-DOG IgE MONOCLONAL ANTIBODY |
09/25/2014 | WO2014148429A1 Biomarker for diagnosing nonspecific interstitial pneumonia |
09/25/2014 | WO2014147873A1 Antibody that binds specifically with hmgb1 decomposition product, and method and reagent for assaying hmgb1 decomposition product |
09/25/2014 | WO2014147649A2 One pot process for the preparation of gold quantum clusters |
09/25/2014 | WO2014147642A1 Substituted fluoranthene-7-carbonitriles as fluorescent dyes for cell imaging applications |
09/25/2014 | WO2014147629A1 Anti-biofilm screening assays |
09/25/2014 | WO2014147628A1 Bacterial immunoassay |
09/25/2014 | WO2014147615A1 Determination of renal function level using creatinine and urea labeled by a stable isotope |
09/25/2014 | WO2014147509A1 Clinical decision support (cds) for radiotherapy in prostate cancer |
09/25/2014 | WO2014147487A2 Method for determining degree of modified potency of bipathic medicament |
09/25/2014 | WO2014147484A2 Brucellosis, q-fever, and lyme disease biomarkers and uses thereof |
09/25/2014 | WO2014147416A1 Measurement of tissue structures |
09/25/2014 | WO2014147404A1 Prenatal screening |
09/25/2014 | WO2014147395A1 Materials and methods for analysing glycation |
09/25/2014 | WO2014147379A1 Weight measurement device and system for enabling the determination and/or monitoring of alcohol consumption |
09/25/2014 | WO2014147288A1 Luminescent triazacyclononane-based lanthanide chelate complexes as labelling reagents |
09/25/2014 | WO2014147216A1 In vitro method for assessing cytokine storm responses |
09/25/2014 | WO2014147193A1 New cell-penetrating peptide motifs |
09/25/2014 | WO2014147191A1 Self-cell penetrating fluorescent peptide biosensors to probe and quantify cdk/cyclin kinases |
09/25/2014 | WO2014147153A1 Adrenomedullin to guide therapy of blood pressure decline |
09/25/2014 | WO2014147139A1 Sensor device |
09/25/2014 | WO2014147121A1 Method and reagent for determining vitamin d metabolites |
09/25/2014 | WO2014147101A1 Specific detection of rat antibodies in mouse serum |
09/25/2014 | WO2014147074A1 Method / device for generating a corrected value of an analyte concentration in a sample of a body fluid |
09/25/2014 | WO2014147049A1 No-wash magneto-electrochemical procedure to detect an analyte in a sample |
09/25/2014 | WO2014147018A1 Tool for the manufacture of calibrated fissures |
09/25/2014 | WO2014147015A1 Apparatus and method for sampling and analyzing breath |